We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 12.50 | 0.71% | 1,773.50 | 1,772.00 | 1,772.50 | 1,776.00 | 1,766.00 | 1,770.00 | 6,684,113 | 16:35:11 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.81 | 72.97B |
From May 2019 to May 2024
TIDMGSK
RNS Number : 4806Y
GlaxoSmithKline PLC
01 December 2014
GlaxoSmithKline plc
Total Voting Rights and Capital
In conformity with Disclosure and Transparency Rule 5.6.1R, GlaxoSmithKline plc (the 'Company') hereby notifies the market of the following:
The Company's issued share capital as at 30 November 2014 consisted of 5,354,848,976 Ordinary Shares of 25p each, of which 491,515,950 Ordinary Shares were held in Treasury.
Therefore, the total number of voting rights in the Company is 4,863,333,026. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.
V A Whyte
Company Secretary
1 December 2014
This information is provided by RNS
The company news service from the London Stock Exchange
END
TVRUGGRPPUPCGPG
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
